Teladoc Health, Inc.TDOCNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank8
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P8
Near historical low
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-9.55%
2024-11.83%
20234.46%
20226.97%
202189.09%
2020155.15%
201918.89%
201857.79%
201757.96%
201653.52%